Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...

Pharmaceutical companies have already raised the price of over 800 brand-name prescription drugs this year. Nearly all the ...

With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform. | Neomorph is ...